What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

03/10/2015 - 1 minute

Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping)


Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments?


Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?


Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government


Friday: Merck relinquishes Rare Disease license to instead focus on Immuno-oncology


Weekend: We will celebrate German unity on Saturday.

Related Content

reichstag-324982_1280

ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

You might also be interested in the following:


Support Us

Become a Member